| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1687.48 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1141.79 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1092.19 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 1713.29 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1129.12 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1158.69 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1085.46 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1637 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1425.47 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1002.29 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1675.6 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1323.1 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1813.47 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1320.02 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1718.86 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1761.3 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1324.85 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1568.97 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1607.38 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1863.84 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1399.67 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1536.06 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1354.66 | 97 |